期刊文献+

独山瓜馥木提取物促休眠型结核杆菌复苏的活性研究(英文) 被引量:5

Resuscitating Activity of Fissistigma cavaleriei Extract on Dormant Mycobacteria
下载PDF
导出
摘要 结核杆菌具有休眠的特性,休眠型结核杆菌对现有抗痨药物均不敏感,因此研发抗休眠型结核杆菌药物对根治结核病具有重要意义。本试验采用Wayne模型,发现独山瓜馥木根的乙醇提取物能复苏休眠型结核杆菌,独山瓜馥木的促复苏作用可能与刺激休眠型结核杆菌利用C10化合物作为能量来源有关。在体外试验时,独山瓜馥木根的乙醇提取物(2 mg/m L)与异烟肼(8μg/m L)联合用药,可杀死休眠型结核杆菌。结果提示,传统抗痨药物与促进休眠型结核杆菌复苏的药物联合用药可能是根治结核病的一种新策略。 Mycobacterium tuberculosis could go into nonreplicative dormancy.This stage of mycobacteria posed a significant problem for effective therapy as these persistent bacilli were resistant to most of the currently available drugs for the treatment of tuberculosis.The development of drugs that specifically target dormant bacilli could have a profound impact on tuberculosis therapy.In the present study,the extract of Fissistigma cavaleriei root showed a potential activity to resuscitate dormant tubercle bacillus into active bacilli based on Wayne model.It seemed that F.cavaleriei extract might stimulate dormant M.tuberculosis to use compounds of C10 as energy sources for resuscitation.The combination of F.cavaleriei extract (2 mg/mL) and isoniazid (8 μg/mL) showed powerful killing effect on dormant M.tuberculosis. The findings of this study suggested that conventional anti-mycobacterials in combination with ‘dormancy-regrowth’ drugs might be considered as a novel strategy to eradicate latent M.tuberculosis.
出处 《天然产物研究与开发》 CAS CSCD 北大核心 2015年第7期1219-1224,共6页 Natural Product Research and Development
基金 National Natural Science Foundation of China(NSFC81460531) TCM Project of Guizhou Province(ZY2012-3011) Social Development and Scientific Project of Guizhou Province(SY2013-3058)
关键词 独山瓜馥木 复苏 休眠型结核杆菌 Fissistigma cavaleriei resuscitation dormant Mycobacterium tuberculosis
  • 相关文献

参考文献15

  • 1Stanford J, Stanford C. Mycobacteria and their world. Int J Mycobacteriol ,2012 ,1: 3-12.
  • 2Zumla A, Nahid P, Cole ST. Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discov ,2013 ,12 :388-404.
  • 3Filippini P, Ions E, Piccaro G, et al. Activity of drug combi- nations against dormant Mycobacterium tuberculosis. Antimi- crob Agents Chemother,2010,54:2712-2715.
  • 4Shim TS ,Jo KW. Medical treatment of pulmonary multidrug- resistant tuberculosis. Infect Chemother , 2013 , 4 5 : 3 6 7-3 7 4.
  • 5Scidi K,Jahanban-Esfahlan R. A novel approach to eradicate latent TB: based on resuscitation promoting factors. J Med Hypotheses Ideas ,2013,7:69-74.
  • 6Bao J, Ran MX. The Studies and Development of Miao Peo- ple Medicine in Guizhou Province. Guiyang:Guizhou Science and Technology Press, First Edition, 1987.
  • 7Yang Z, Niu Y, Qiao C. Beta-lactamase inhibitory component from the roots of Fissistigma cavaleriei. Phytomedicine ,2010, 17:139-141.
  • 8Yang Z, Lu W, Ma X, et al. Bioassay-guided isolation of an alkaloid with antiangiogenic and antitumor activities from the extract of Fissistigma cavaleriei root. Phytomedicine , 2012, 19:301-305.
  • 9Wayne LG, Hayes LG. An in vitro model for sequential study of shift down of Mycobacterium tuberculosis through two stages of nonrepllcafing persistence. Infect lmmun, 1996,64 : 2062- 2069.
  • 10Lenaerts AJ, Gruppo V, Marietta KS. Preclinical testing of the nitmimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models. Antimi- crob Agents Chemother ,2005 ,49 :2294-2301.

同被引文献39

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部